Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 746

1.

Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.

Sellers ZP, Bolkun L, Kloczko J, Wojtaszewska ML, Lewandowski K, Moniuszko M, Ratajczak MZ, Schneider G.

Clin Epigenetics. 2019 Mar 15;11(1):50. doi: 10.1186/s13148-019-0643-z.

2.

Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.

Han YD, Oh TJ, Chung TH, Jang HW, Kim YN, An S, Kim NK.

Clin Epigenetics. 2019 Mar 15;11(1):51. doi: 10.1186/s13148-019-0642-0.

3.

Genetic regulation of methylation in human endometrium and blood and gene targets for reproductive diseases.

Mortlock S, Restuadi R, Levien R, Girling JE, Holdsworth-Carson SJ, Healey M, Zhu Z, Qi T, Wu Y, Lukowski SW, Rogers PAW, Yang J, McRae AF, Fung JN, Montgomery GW.

Clin Epigenetics. 2019 Mar 14;11(1):49. doi: 10.1186/s13148-019-0648-7.

4.

Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study.

Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC.

Clin Epigenetics. 2019 Mar 12;11(1):45. doi: 10.1186/s13148-019-0641-1.

5.

SOX2 promoter hypermethylation in non-smoking Taiwanese adults residing in air pollution areas.

Tantoh DM, Wu MF, Ho CC, Lung CC, Lee KJ, Nfor ON, Liaw YC, Hsu SY, Chen PH, Lin C, Chu HW, Liaw YC, Liaw YP.

Clin Epigenetics. 2019 Mar 12;11(1):46. doi: 10.1186/s13148-019-0647-8.

6.

Correction to: Liver DNA methylation of FADS2 associates with FADS2 genotype.

Walle P, Männistö V, de Mello VD, Vaittinen M, Perfilyev A, Hanhineva K, Ling C, Pihlajamäki J.

Clin Epigenetics. 2019 Mar 12;11(1):47. doi: 10.1186/s13148-019-0625-1.

7.

The hyper-activation of transcriptional enhancers in breast cancer.

Li QL, Wang DY, Ju LG, Yao J, Gao C, Lei PJ, Li LY, Zhao XL, Wu M.

Clin Epigenetics. 2019 Mar 12;11(1):48. doi: 10.1186/s13148-019-0645-x.

8.

RFX1 downregulation contributes to TLR4 overexpression in CD14+ monocytes via epigenetic mechanisms in coronary artery disease.

Du P, Gao K, Cao Y, Yang S, Wang Y, Guo R, Zhao M, Jia S.

Clin Epigenetics. 2019 Mar 11;11(1):44. doi: 10.1186/s13148-019-0646-9.

9.

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming.

Torrano J, Al Emran A, Hammerlindl H, Schaider H.

Clin Epigenetics. 2019 Mar 8;11(1):43. doi: 10.1186/s13148-019-0644-y. Review.

10.

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.

Gu S, Lin S, Ye D, Qian S, Jiang D, Zhang X, Li Q, Yang J, Ying X, Li Z, Tang M, Wang J, Jin M, Chen K.

Clin Epigenetics. 2019 Mar 7;11(1):41. doi: 10.1186/s13148-019-0628-y.

11.

Temple syndrome in a patient with variably methylated CpGs at the primary MEG3/DLK1:IG-DMR and severely hypomethylated CpGs at the secondary MEG3:TSS-DMR.

Kagami M, Yanagisawa A, Ota M, Matsuoka K, Nakamura A, Matsubara K, Nakabayashi K, Takada S, Fukami M, Ogata T.

Clin Epigenetics. 2019 Mar 7;11(1):42. doi: 10.1186/s13148-019-0640-2.

12.

Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.

Li S, Yuan Y, Xiao H, Dai J, Ye Y, Zhang Q, Zhang Z, Jiang Y, Luo J, Hu J, Chen C, Wang G.

Clin Epigenetics. 2019 Mar 4;11(1):38. doi: 10.1186/s13148-019-0619-z.

13.

A comparison of DNA methylation in newborn blood samples from infants with and without orofacial clefts.

Xu Z, Lie RT, Wilcox AJ, Saugstad OD, Taylor JA.

Clin Epigenetics. 2019 Mar 4;11(1):40. doi: 10.1186/s13148-019-0638-9.

14.

Serum cell-free DNA methylation of OPCML and HOXD9 as a biomarker that may aid in differential diagnosis between cholangiocarcinoma and other biliary diseases.

Wasenang W, Chaiyarit P, Proungvitaya S, Limpaiboon T.

Clin Epigenetics. 2019 Mar 4;11(1):39. doi: 10.1186/s13148-019-0634-0.

15.

Exploring the unique function of imprinting control centers in the PWS/AS-responsible region: finding from array-based methylation analysis in cases with variously sized microdeletions.

Matsubara K, Itoh M, Shimizu K, Saito S, Enomoto K, Nakabayashi K, Hata K, Kurosawa K, Ogata T, Fukami M, Kagami M.

Clin Epigenetics. 2019 Feb 28;11(1):36. doi: 10.1186/s13148-019-0633-1.

16.

Genome-wide DNA methylation and long-term ambient air pollution exposure in Korean adults.

Lee MK, Xu CJ, Carnes MU, Nichols CE, Ward JM; BIOS consortium, Kwon SO, Kim SY, Kim WJ, London SJ.

Clin Epigenetics. 2019 Feb 28;11(1):37. doi: 10.1186/s13148-019-0635-z.

17.

The emerging role of epigenetics in human autoimmune disorders.

Mazzone R, Zwergel C, Artico M, Taurone S, Ralli M, Greco A, Mai A.

Clin Epigenetics. 2019 Feb 26;11(1):34. doi: 10.1186/s13148-019-0632-2. Review.

18.

Differences in expression rather than methylation at placenta-specific imprinted loci is associated with intrauterine growth restriction.

Monteagudo-Sánchez A, Sánchez-Delgado M, Mora JRH, Santamaría NT, Gratacós E, Esteller M, de Heredia ML, Nunes V, Choux C, Fauque P, de Nanclares GP, Anton L, Elovitz MA, Iglesias-Platas I, Monk D.

Clin Epigenetics. 2019 Feb 26;11(1):35. doi: 10.1186/s13148-019-0630-4.

19.

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients.

Pineda B, Diaz-Lagares A, Pérez-Fidalgo JA, Burgués O, González-Barrallo I, Crujeiras AB, Sandoval J, Esteller M, Lluch A, Eroles P.

Clin Epigenetics. 2019 Feb 20;11(1):33. doi: 10.1186/s13148-019-0626-0.

20.

Epigenetic impacts of maternal tobacco and e-vapour exposure on the offspring lung.

Zakarya R, Adcock I, Oliver BG.

Clin Epigenetics. 2019 Feb 19;11(1):32. doi: 10.1186/s13148-019-0631-3. Review.

Supplemental Content

Loading ...
Support Center